Markets.com Logo

NRXP

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    2.6119$
  • Previous Close
    2.5265$
  • 52 Week Change
    4.91$
  • Day Range
    0.09$
  • 52 Week High/Low
    1.1$ - 6.01$
  • Dividend Per Share
    --
  • Market cap
    51 627 K$
  • EPS
    -0.98
  • Beta
    1.601
  • Volume
    --

About

NRXP.US refers to NeuroRx, Inc., a biopharmaceutical company focused on developing novel therapeutics for the treatment of central nervous system disorders and life-threatening respiratory illnesses. The ".US" suffix indicates that the stock is traded on a United States stock exchange. NeuroRx has been developing treatments for conditions such as suicidal depression, acute respiratory distress syndrome (ARDS) including that associated with COVID-19, and chronic pain. The company's stock price and performance are subject to market fluctuations and are influenced by factors such as clinical trial results, regulatory approvals, and overall market sentiment regarding the biotechnology and pharmaceutical industries.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Clinical Trial Results: Positive or negative data from clinical trials of NRx Pharmaceuticals' drug candidates significantly impacts investor confidence and stock price.

Regulatory Decisions: FDA approvals, rejections, or delays for NRx Pharmaceuticals' products directly influence revenue potential and investor sentiment.

Financial Performance: The company's cash position, burn rate, and any announcements regarding funding or partnerships affect investor perception of long-term viability.

Market Conditions: Overall market sentiment, particularly within the biotechnology sector, can influence the price of NRXP.US, regardless of company-specific news.

Competition: The competitive landscape, including progress made by rival companies in developing similar treatments, can affect NRx Pharmaceuticals' market share potential.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--